Neuroscience
We’re seeking greater understanding of the genetics and pathophysiology of diseases of the brain and nervous system, and improving the diagnosis and surgical, medical and psychological management of neurological disease, intellectual disability and cognitive health.
Program Leaders
Our Neuroscience Program Leaders are supported by six Neuroscience Program Group Leaders and a team of more than 30 group members. View a full listing of Neuroscience Program researchers.
Program Groups
Cognitive Health Genomics
Cognitive Neurology
Genome Plasticity and Disease Research
Glial Neurobiology, Cognition and Behaviour Research
Mater Epilepsy Unit Research
Neural Stem Cell Biology Research
Neurodevelopmental Research
Neuroimmunology Research
Queensland Centre of Excellence in Autism and Intellectual Disability Health
Clinical Trials
Clinical trials are an essential component of modern healthcare and provide evidence to evaluate the safety and efficacy of new treatments, diagnostics and health interventions and offer alternative options for patients with unmet needs under current standards of care. Explore Neuroscience Program clinical trials currently running at Mater Research below or learn more about Mater Clinical Trials.
-
Maplight - An experimental drug to moderate behavioural symptoms in people with autism
-
RESOLUTION – Preventative treatment for migraine in patients with medication overuse headaches
-
UMPIRE - Trial of an implantable device for continuous monitoring of epileptic seizure activity.
-
X-ACKT: Clinical trial of a new drug for generalised epilepsy
-
X-TOLE2: Clinical trial of a new drug for focal epilepsy
